|
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
|
Richard Lafayette
Jackson Kim, MD
|
Recruiting
|
|
Transformative Research in Diabetic Nephropathy
|
Richard Lafayette
|
Recruiting
|
|
Sit Less, Interact and Move More (SLIMM) 2 Study
|
Glenn M. Chertow
|
Recruiting
|
|
Nephrotic Syndrome Study Network
|
Richard Lafayette
Jackson Kim, MD
|
Recruiting
|
|
Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy
|
Richard Lafayette
|
Recruiting
|
|
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - a Randomized Clinical Trial in Acute Kidney Injury
|
Glenn M. Chertow
Vikram Fielding-Singh
|
Recruiting
|
|
FIH Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy
|
Richard Lafayette
Kevin Graber, MD
Jaimie Henderson, MD
Vivek P. Buch, MD
|
Recruiting
|
|
KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
|
Richard Lafayette
|
Recruiting
|
|
Global Kidney Patient Trials Network
|
Margaret Yu
|
Recruiting
|
|
Developing Tools for Dialysis Decision Support
|
Manjula Kurella Tamura
Margaret Yu
|
Recruiting
|
|
Delayed Blood Stem Transplantation in HLA Matched Kidney Transplant Recipients to Eliminate Immunosuppressive Drugs.
|
Stephan Busque
Robert Lowsky
John Scandling
Judith Shizuru
Everett Meyer
Khoa Thomas Pham
|
Recruiting
|
|
Belimumab With Rituximab for Primary Membranous Nephropathy
|
Richard Lafayette
Jackson Kim, MD
|
Recruiting
|
|
Belimumab in Remission of VASculitis
|
Richard Lafayette
|
Recruiting
|
|
Accelerated Intermittent Theta-Burst Stimulation (aiTBS) in Treatment-Resistant Depression of Bipolar II Disorder
|
Daniel Kim
Ian H. Kratter, MD, PhD
Jackson Kim, MD
|
Recruiting
|
|
A Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS)
|
Richard Lafayette
|
Recruiting
|
|
A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy
|
Richard Lafayette
Jackson Kim, MD
|
Recruiting
|
|
A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old
|
Richard Lafayette
|
Recruiting
|
|
Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients
|
Richard Lafayette
|
Recruiting
|